Luccarelli James, Smith Joshua R, Kalinich Mark, Amad Ali, Rogers Jonathan P
Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston (Luccarelli); Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center at Village of Vanderbilt, and Vanderbilt Kennedy Center, Vanderbilt University, Nashville (Smith); Department of Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston (Kalinich); Lille Neuroscience and Cognition, University of Lille, Lille, France (Amad); Division of Psychiatry, University College London, London (Rogers).
J Neuropsychiatry Clin Neurosci. 2025 Spring;37(2):160-162. doi: 10.1176/appi.neuropsych.20240072. Epub 2025 Jan 10.
Catatonia is a neuropsychiatric disorder that is associated with a range of medical and psychiatric illnesses. Although many single-center studies have been conducted, uncertainty over the population-based incidence and prevalence of the disorder remains. This study reports on the incidence and prevalence rates of catatonia extrapolated from two large epidemiologic studies in the United Kingdom and United States.
Incidence rates (defined as the number of catatonic episodes per 100,000 person-years) and prevalence rates (defined as the proportion of individuals with catatonia in a given year) were calculated from the two studies.
U.K. data showed an incidence of 4.34 (95% CI=3.98-4.72) catatonic episodes per 100,000 person-years with an average 1-year prevalence of 4.39 (95% CI=4.03-4.77) catatonic episodes per 100,000 persons. U.S. data revealed a 1-year prevalence of 5.15 (95% CI=5.08-5.23) catatonia-related hospitalizations per 100,000 persons.
Catatonia is a rare disorder, qualifying as an orphan disease under both European Medicines Agency and U.S. Food and Drug Administration criteria. Further research is needed to rigorously define the epidemiology of catatonia in other populations.
紧张症是一种神经精神障碍,与一系列医学和精神疾病相关。尽管已经开展了许多单中心研究,但该疾病基于人群的发病率和患病率仍存在不确定性。本研究报告了从英国和美国两项大型流行病学研究中推断出的紧张症发病率和患病率。
从这两项研究中计算发病率(定义为每10万人年的紧张症发作次数)和患病率(定义为特定年份中患有紧张症的个体比例)。
英国数据显示,每10万人年的紧张症发病率为4.34(95%置信区间=3.98 - 4.72)次发作,每10万人的平均1年患病率为4.39(95%置信区间=4.03 - 4.77)次发作。美国数据显示,每10万人中与紧张症相关的住院治疗1年患病率为5.15(95%置信区间=5.08 - 5.23)。
紧张症是一种罕见疾病,根据欧洲药品管理局和美国食品药品监督管理局的标准,可被认定为罕见病。需要进一步研究以严格界定其他人群中紧张症的流行病学情况。